Home › Aldermeesklierkanker › Nebraska › Omaha
Aldermeesklierkanker klinische studies in Omaha, NE
14 studies voor Aldermeesklierkanker zoeken deelnemers op locaties in en rond Omaha (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruterenFase 1
- Nebraska Cancer Specialists, Omaha
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruterenFase 2/3
- Nebraska Medicine, Omaha
- Nebraska Medicine - Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 3
- University of Nebraska Medical Center, Omaha
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruterenFase 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RekruterenObservatieonderzoek
- University of Nebraska Medical Center, Omaha
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruterenFase 3
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
Pancreatic Cancer Early Detection Consortium
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- University of Nebraska Medical Center, Omaha
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RekruterenFase 2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- en nog 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruterenFase 1
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399, Omaha
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekruterenFase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- en nog 1
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Nebraska Cancer Specialists, Omaha
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruterenFase 2
- Ohio State University-Telemedicine, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Omaha
Aldermeesklierkanker studies in andere steden
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Andere studies in Omaha
- Prostaatkanker27 studies
- Niet-kleincellige longkanker24 studies
- Borstkanker22 studies
- Kanker (alle vormen)18 studies
- Colorectale kanker18 studies
- Multipel myeloom16 studies
- Eierstokkanker14 studies
- Non-Hodgkinlymfoom14 studies
- Metastatische kanker13 studies
- Plaveiselcelcarcinoom van hoofd en hals13 studies
- Hartfalen13 studies
- Melanoom12 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.